Cargando…

Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer

As a type of immunogenic cell death, ferroptosis participates in the creation of immunoactive tumor microenvironments. However, knowledge of spatial location of tumor cells with ferroptosis signature in tumor environments and the role of ferroptotic stress in inducing the expression of immune‐relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Chih‐Hung, Lin, Chun‐Yu, Chen, Chih‐Yu, Hsueh, Chun‐Wei, Chang, Yao‐Wen, Wang, Chen‐Chi, Chu, Pen‐Yuan, Tai, Shyh‐Kuan, Yang, Muh‐Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214241/ https://www.ncbi.nlm.nih.gov/pubmed/37026630 http://dx.doi.org/10.1002/advs.202204514

Ejemplares similares

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
por: Hu, Ming-Hung, et al.
Publicado: (2014)

PD-L1 expression is associated with p16(INK4A) expression in non-oropharyngeal head and neck squamous cell carcinoma
por: Chen, San-Chi, et al.
Publicado: (2018)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
por: Chen, Tien-Hua, et al.
Publicado: (2022)

Immune Checkpoint Inhibition in Head and Neck Cancer
por: Forster, Martin David, et al.
Publicado: (2018)

NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment
por: Wang, Yi-Fen, et al.
Publicado: (2014)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
por: Chen, Zhuohui, et al.
Publicado: (2021)

Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy
por: Lu, Hsueh-Ju, et al.
Publicado: (2019)

Immune and genomic signatures in oral (head and neck) cancer
por: Chakraborty, Prasenjit, et al.
Publicado: (2018)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yu, Jiangang, et al.
Publicado: (2022)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma
por: Lee, Tsung-Lun, et al.
Publicado: (2022)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Stage-dependent angiopoietin-Tie2 and nitric oxide signaling of erythrocytes in response to surgical trauma in head and neck cancer
por: Wu, Hsiang-Ling, et al.
Publicado: (2020)

Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
por: Tseng, Jen-Chih, et al.
Publicado: (2021)

Retiform Hemangioendothelioma of the Neck
por: Kuo, Chin-Lung, et al.
Publicado: (2015)

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
por: Chuang, Fu-Cheng, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma
por: Xu, Li, et al.
Publicado: (2021)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
por: Wang, Haiyang, et al.
Publicado: (2019)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2022)

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
por: Pan, Yi-Ru, et al.
Publicado: (2022)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
por: Lee, Chih-Chan, et al.
Publicado: (2018)

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
por: Yan, Yu-Chuan, et al.
Publicado: (2022)

Iron, Ferroptosis, and Head and Neck Cancer
por: Teng, Yong, et al.
Publicado: (2023)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Using machine learning algorithm to analyse the hypothyroidism complications caused by radiotherapy in patients with head and neck cancer
por: Lee, Tsair-Fwu, et al.
Publicado: (2023)

Novel Prognostic Model Based on Immune Signature for Head and Neck Squamous Cell Carcinoma
por: Wang, Yingying, et al.
Publicado: (2020)

Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma
por: Yang, Chun‐Bo, et al.
Publicado: (2022)

Snail-overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes
por: Hsieh, Chia-Hsin, et al.
Publicado: (2018)

5-Methoxytryptophan Sensitizing Head and Neck Squamous Carcinoma Cell to Cisplatitn Through Inhibiting Signal Transducer and Activator of Transcription 3 (STAT3)
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations
por: Davis, Ruth J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nj8as3eoq7nli9pk3jvvmk2u5v